Amgen's AMG 510 inhibits tumor growth in mice

Amgen reported the first preclinical data for its small molecule G12C-mutant K-Ras (KRAS) inhibitor, AMG 510, at the American Association for Cancer Research (AACR) meeting in Atlanta.

Amgen Inc. (NASDAQ:AMGN) said AMG 510 significantly decreased tumor volume in mouse xenograft models of pancreatic and lung cancer vs. vehicle controls...